cerca CERCA
Mercoledì 21 Aprile 2021
Aggiornato: 06:58
Temi caldi


Aran Biomedical Expansion: Galway Implantable Device Manufacturer to create 150 New Jobs

GALWAY, Ireland, April 12, 2021 /PRNewswire/ -- In response to growing business demand, Aran Biomedical Teoranta, a leading biomaterials contract manufacturer of proprietary medical devices, today announced the creation of 150 new jobs over 3 years. Additionally, the Company announced its plan to build a new, purpose-built facility in Spiddal, Galway. The investment is supported by the Irish Government, through Údarás na Gaeltachta.

alternate text

Digitalizzazione e umanizzazione in home care

Ecco i modelli italiani per far fronte alla pandemia delle malattie croniche. Gli specialisti: «Gli applicativi gestionali devono semplificare il lavoro del medico di medicina generale abbattendo i carichi burocratici e semplificandogli il lavoro».

Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T

SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo wil...

License and Commercialization agreement between Pierre Fabre and ValenzaBio on an anti-IGF-1R antibody for the development of a novel treatment in Thyroid Eye Disease (TED)

BESTHESDA, Maryland and CASTRES, France, April 8, 2021 /PRNewswire/ -- The US biopharmaceutical company ValenzaBio and the French pharmaceutical group Pierre Fabre announced today the signing of a license agreement of a preclinical insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody, for the treatment of Thyroid Eye Disease (TED), an endocrine disease with unmet medical need. ValenzaBio received from Pierre Fabre the worldwide and exclusive rights to develop and commercialize, outs...

Bionical Emas launches Managed Access Program for JZP 458 - a recombinant Crisantaspase produced in Pseudomonas fluorescens

WILLINGTON, England, April 8, 2021 /PRNewswire/ -- Bionical Emas, a global specialist Clinical Research Organization (CRO) has today announced the launch of a Managed Access Program for Jazz Pharmaceuticals' medicinal product JZP-458 for the treatment of patients with Acute Lymphoblastic Leukaemia (ALL) and Lymphoblastic Lymphoma (LBL) following hypersensitivity to E. Coli-derived asparaginases. The Managed Access Program provides a mechanism through which unsolicited physician requests, to fulfi...

LumiThera annuncia i dati top dello studio clinico europeo multicentrico LIGHTSITE II per il trattamento della degenerazione maculare senile secca

SEATTLE, 7 aprile 2021 /PRNewswire/-- LumiThera, Inc., azienda di dispositivi medici in fase commerciale che fornisce il trattamento di fotobiomodulazione (PBM) per disturbi e malattie oculari, ha oggi annunciato di aver ottenuto dei risultati positivi in LIGHTSITE II, lo studio clinico multicentrico condotto su pazienti affetti da degenerazione maculare senile (DMLE) secca.

Khiron Expands Product Offering in UK and Increases Patient Access

TORONTO, April 7, 2021 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs, the Company has established an offshore inventory of dried flower, for the express purpose of serving UK...

ora in
Prima pagina
Tag più usati
in questa pagina

motore sanità

salute_e_benessere salute_e_benessere chimica_e_farmacia economia_e_finanza


regione toscana


accelerate clinical trials

aderenza terapeutica


altroaltro salute_e_benessere altro economia_e_finanza

approvazione della commissione europea

in Evidenza